|
|
ASH 2011: Dr. Richardson - Phase II Study of the Pan-Deacetylase Inhibitor Panobinostat in Combination with Bortezomib and Dexamethasone in Relapsed and Bortezomib-Refractory Multiple Myeloma (PANORAMA 2)
Paul G. Richardson, MD
Dana-Farber Cancer Institute
Boston, Massachusetts, USA
|
|
|
back
button next to the volume control in the
lower right hand corner.
print
related articles